COMMUNIQUÉS West-GlobeNewswire

Samumed Announces Publication of Preclinical Data Demonstrating That SM07883 is a Potential Treatment for Alzheimer’s Disease
18/07/2019
SAN DIEGO, July 18, 2019 (GLOBE NEWSWIRE) -- Samumed, LLC, announced today the publication of preclinical data demonstrating that SM07883 inhibits tau pathology and associated neuroinflammation, both of which are [...]
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data and Artificial Intelligence-Driven Approach to Treating Ovarian Cancer
18/07/2019
PITTSBURGH, July 18, 2019 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) subsidiary Helomics, an artificial intelligence (AI) and data-driven functional precision medicine company with the mission of improving [...]
Chembio Diagnostics and Takeda Pharmaceutical Company Enter Collaboration to Develop Point-of-Care Diagnostic Test
18/07/2019
MEDFORD, N.Y., July 18, 2019 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care (POC) diagnostics company focused on infectious diseases, today announced that it has entered into a [...]
The New Hemp Energy Drink Will Be Offered to Consumers in 700 Additional Stores in Five Provinces
18/07/2019
OTTAWA, ON, July 18, 2019 (GLOBE NEWSWIRE) -- Tetra Natural Heath, a subsidiary of Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), is pleased to announce that one of the largest food and convenience store chains in [...]
Progressive Care Inc. Garners Coverage in Publicly Traded Podcasts
18/07/2019
MIAMI, July 18, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered media coverage in Publicly Traded Podcasts’ [...]
Adaptimmune Starts the SURPASS Clinical Trial with its first Next-Generation SPEAR T-cells Targeting MAGE‑A4 to Enhance Antitumor Responses
18/07/2019
These next-generation SPEAR T-cells may improve long term T-cell functions PHILADELPHIA and OXFORDSHIRE, United Kingdom, July 18, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc, Philadelphia, PA, and Oxfordshire [...]
Iovance Biotherapeutics Appoints Friedrich Graf Finckenstein, M.D., as Chief Medical Officer
18/07/2019
SAN CARLOS, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL [...]
The Joint Corp. Acquires Four Clinics
18/07/2019
- Enters the Growing Georgia/South Carolina Market with Three Clinics - - Expands the Phoenix, Arizona Corporate Portfolio - SCOTTSDALE, Ariz., July 18, 2019 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a [...]
HempAmericana Announces Dramatic Rise in Its CBD Production and Inventory
18/07/2019
NEW YORK, July 18, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”), an emerging participant in the CBD products market, is excited to update shareholders on [...]
AuDStandard Announces Partnership With Hear Billing Solutions (HBS)
18/07/2019
PEARLAND, Texas, July 18, 2019 (GLOBE NEWSWIRE) -- AuDStandard, an unbundled hearing aid buying group that provides exclusive pricing, practice growth solutions, detailed analytics and other services to hearing [...]
Olivier Chaudoir Joins BioSig as Director of Marketing
18/07/2019
Electrophysiology marketing leader to drive market adoption strategy for PURE EP™ System Westport, CT, July 18, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a [...]
Agile Therapeutics Appoints Chief Financial Officer
18/07/2019
Dennis P. Reilly to bring commercial experience to management team Appointment Effective August 5, 2019 PRINCETON, N.J., July 18, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare [...]
Centrexion Therapeutics to Present New Positive Clinical Trial Results on Streamlined CNTX-4975 Administration Techniques
18/07/2019
-- Administration procedure designed to optimize physician and patient experience and convenience -- -- Company also shares interim analysis of 719 patients in VICTORY-3 Phase 3 open-label trial indicating the studied [...]
Blueberries Medical Makes Significant Advances Towards Commercial Production & Provides Operational and Corporate Update
18/07/2019
TORONTO, July 18, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a leading Latin American licensed producer of medicinal cannabis and cannabis [...]
CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot
18/07/2019
NEWS HIGHLIGHTS CB2 Insights has been selected as exclusive research technology platform for the UK’s largest medical cannabis Pilot - Project TWENTY21 Project TWENTY21 aims to enroll 20,000 patients into the Pilot and [...]
CB2 Insights Selected by Drug Science as Research Technology Platform for the UK’s Largest Medical Cannabis Pilot
18/07/2019
NEWS HIGHLIGHTS CB2 Insights has been selected as exclusive research technology platform for the UK’s largest medical cannabis Pilot - Project TWENTY21 Project TWENTY21 aims to enroll 20,000 patients into the Pilot and [...]
Clearside Biomedical Announces Multiple Oral Presentations to be Given at the American Society of Retinal Specialists (ASRS) Annual Meeting
18/07/2019
- Presentations include clinical experience of the SCS Microinjector™ and a video presentation on suprachoroidally delivered gene therapy - ALPHARETTA, Ga., July 18, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. ( [...]
Agios to Webcast Conference Call of Second Quarter 2019 Financial Results on August 1, 2019
18/07/2019
CAMBRIDGE, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company [...]
Inivata announces launch of clinical trial to evaluate impact of InVisionFirst®-Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer
18/07/2019
Inivata announces launch of clinical trial to evaluate impact of InVisionFirst ® -Lung liquid biopsy test on time to appropriate treatment in advanced lung cancer Prospective, interventional study sponsored by Centre [...]

Pages